|
Variables
| |
Good glycemic control group
| |
Poor glycemic control group
|
|---|
|
OR (95% CI)
|
P value
|
OR (95% CI)
|
P value
|
|---|
| |
Model 1A
| | |
Model 1B
| | |
|
Male
| |
1.492 (0.137–16.197)
|
0.742
| |
8.47 (0.6–119.56)
|
0.114
|
|
Age
| |
0.973 (0.874–1.084)
|
0.622
| |
0.953 (0.806–1.126)
|
0.573
|
|
Body mass index
| |
0.882 (0.585–1.328)
|
0.547
| |
1.592 (0.954–2.656)
|
0.075
|
|
Smoke
| |
1.800 (0.372–8.719)
|
0.465
| |
3.588 (0.573–22.482)
|
0.172
|
|
Hypertension
| |
7.320 (1.167–45.933)
|
0.034
| |
3.332 (0.435–25.548)
|
0.247
|
|
Total-to-HDL cholesterol ratio
| |
0.983 (0.503–1.923)
|
0.960
| |
8.945 (2.004–39.919)
|
0.004
|
|
GFR
| |
0.962 (0.898–1.030)
|
0.269
| |
0.948 (0.866–1.037)
|
0.243
|
|
Log-transferred hsCRP
| |
0.984 (0.539–1.795)
|
0.958
| |
1.415 (0.701–2.857)
|
0.333
|
| |
Model 2A
| | |
Model 2B
| | |
|
Male
| |
2.668 (0.187–38.168)
|
0.470
| |
14.289 (0.707–288.728)
|
0.083
|
|
Age
| |
0.949 (0.849–1.061)
|
0.358
| |
0.934 (0.774–1.126)
|
0.473
|
|
Body mass index
| |
0.970 (0.622–1.513)
|
0.894
| |
1.753 (0.943–3.258)
|
0.076
|
|
Smoke
| |
2.408 (0.458–12.679)
|
0.300
| |
3.725 (0.501–27.674)
|
0.199
|
|
Hypertension
| |
8.476 (1.202–59.789)
|
0.032
| |
5.577 (0.470–66.239)
|
0.173
|
|
Total-to-HDL cholesterol ratio
| |
1.158 (0.562–2.389)
|
0.691
| |
11.882 (1.713–82.402)
|
0.012
|
|
GFR
| |
0.964 (0.899–1.034)
|
0.303
| |
0.941 (0.847–1.046)
|
0.261
|
|
Log-transferred hsCRP
| |
0.815 (0.423–1.570)
|
0.540
| |
1.015 (0.462–2.228)
|
0.971
|
|
Tertiles of FMD
| |
0.410 (0.128–1.307)
|
0.132
| |
0.227 (0.056–0.915)
|
0.037
|
- Values are odds ratios (95% confidence interval)
- FMD flow-mediated dilation, GFR glomerular filtration rate, HDL high-density lipoprotein, hsCRP high-sensitivity C-reactive protein
